drugset / Trial / NCT03651882
Oxytocin i.m./i.v. Versus Carbetocin i.v. in Elective Cesarean Sections
RandomizedParallel-groupOpen-labelPrevention
Summary
Objective is to proof non-inferiority of intramyometrial and intravenous oxytocin application compared to intravenous carbetocin for prevention of postpartum hemorrhage in planned, uncomplicated cesarean deliveries.
Timeline
- Start
- 2018-08-07
- Primary completion
- 2022-01-10
- Completion
- 2022-01-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Carbetocin | Peptide | 0.1 mg | Intravenous |
| Comparator | Oxytocin | Peptide | 10 iu | Other |
Indications
No indication recorded.